0

0

0

0

0

0

0

0

0

This article is more than 3 year old.

Johnson & Johnson 'supressed' key facts on faulty hip implant surgeries, says report

Mini

Johnson & Johnson’s Indian arm "suppressed" vital information on the harmful aftermath of hip implant surgeries conducted on numerous patients in the country using faulty hip replacement systems it imported and sold, The Indian Express reported.

Johnson & Johnson 'supressed' key facts on faulty hip implant surgeries, says report
Johnson & Johnson’s Indian arm "suppressed" vital information on the harmful aftermath of hip implant surgeries conducted on numerous patients in the country using faulty hip replacement systems it imported and sold, The Indian Express reported.
The pharma company failed to inform the Medical Council of India (MCI) on the exact number of patients who used its device, the adverse effects following such surgeries and the corrective operations conducted subsequently, the news website said citing findings from a government report.
These findings were part of a report prepared by an expert committee set up by the Union Ministry of Health & Family Welfare to investigate complaints on the hip implant devices sold by the company in India.
The report states that over 3,600 patients with the faulty implants remain untraceable, and that at least four deaths have been reported from those who underwent surgeries using these devices.
The report further claims that the company did not provide any compensation to the people who were affected.
Many patients in India have been adversely affected by the faulty hip replacement surgery they underwent almost a decade ago. The hip implant device, known as DePuy ASR, was manufactured by DePuy Orthopaedics Inc., a fully-owned subsidiary of the $76.4 billion J&J, which is represented in India by the unlisted Johnson & Johnson Private Ltd.
next story